Clinical Trial Update: A Study to Evaluate ABT-450 With Ritonavir (ABT-450/r) and ABT-267 in Japanese Adults With Chronic Hepatitis C Virus Infection [Phase 2]

View source ↗

Summary

Phase 2 study evaluating ABT-450/r and ABT-267 in Japanese adults with chronic hepatitis C completed; results were posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• ABT-267
• ABT-450/r (paritaprevir/ritonavir)

Snippet

Sponsor: AbbVie (prior sponsor, Abbott) | Conditions: Chronic Hepatitis C Infection | Phase 2 | Status: COMPLETED | Results posted: 2015-11-26